In vivo digestomics of milk proteins in human milk and infant formula using a suckling rat pup model

Yasuaki Wada, Brett S. Phinney, Darren Weber, Bo Lönnerdal

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Human milk is the optimal mode of infant feeding for the first several months of life, and infant formulas serve as an alternative when breast-feeding is not possible. Milk proteins have a balanced amino acid composition and some of them provide beneficial bioactivities in their intact forms. They also encrypt a variety of bioactive peptides, possibly contributing to infant health and growth. However, there is limited knowledge of how milk proteins are digested in the gastrointestinal tract and bioactive peptides are released in infants. A peptidomic analysis was conducted to identify peptides released from milk proteins in human milk and infant formula, using a suckling rat pup model. Among the major milk proteins targeted, α-lactalbumin and β-casein in human milk, and β-lactoglobulin and β-casein in infant formula were the main sources of peptides, and these peptides covered large parts of the parental proteins’ sequences. Release of peptides was concentrated to specific regions, such as residues 70–92 of β-casein in human milk, residues 39–55 of β-lactoglobulin in infant formula, and residues 57–96 and 145–161 of β-CN in infant formula, where resistance to gastrointestinal digestion was suggested. In the context of bioactive peptides, release of fragments containing known bioactive peptides was confirmed, such as β-CN-derived opioid and antihypertensive peptides. It is therefore likely that these fragments are of biological significance in neonatal health and development.

Original languageEnglish (US)
Pages (from-to)18-31
Number of pages14
JournalPeptides
Volume88
DOIs
StatePublished - Feb 1 2017

Fingerprint

Infant Formula
Milk Proteins
Human Milk
Rats
Peptides
Caseins
Lactoglobulins
Lactalbumin
Peptide Fragments
Opioid Peptides
Health
Breast Feeding
Antihypertensive Agents
Gastrointestinal Tract
Digestion
Bioactivity
Opioid Analgesics
Amino Acids
Growth

Keywords

  • Bioactive peptides
  • Human milk
  • Infant formula
  • Milk proteins
  • Suckling rat pups

ASJC Scopus subject areas

  • Physiology
  • Biochemistry
  • Endocrinology
  • Cellular and Molecular Neuroscience

Cite this

In vivo digestomics of milk proteins in human milk and infant formula using a suckling rat pup model. / Wada, Yasuaki; Phinney, Brett S.; Weber, Darren; Lönnerdal, Bo.

In: Peptides, Vol. 88, 01.02.2017, p. 18-31.

Research output: Contribution to journalArticle

Wada, Yasuaki ; Phinney, Brett S. ; Weber, Darren ; Lönnerdal, Bo. / In vivo digestomics of milk proteins in human milk and infant formula using a suckling rat pup model. In: Peptides. 2017 ; Vol. 88. pp. 18-31.
@article{84ed5ae305aa4736b3e7bcd73f0b5dbc,
title = "In vivo digestomics of milk proteins in human milk and infant formula using a suckling rat pup model",
abstract = "Human milk is the optimal mode of infant feeding for the first several months of life, and infant formulas serve as an alternative when breast-feeding is not possible. Milk proteins have a balanced amino acid composition and some of them provide beneficial bioactivities in their intact forms. They also encrypt a variety of bioactive peptides, possibly contributing to infant health and growth. However, there is limited knowledge of how milk proteins are digested in the gastrointestinal tract and bioactive peptides are released in infants. A peptidomic analysis was conducted to identify peptides released from milk proteins in human milk and infant formula, using a suckling rat pup model. Among the major milk proteins targeted, α-lactalbumin and β-casein in human milk, and β-lactoglobulin and β-casein in infant formula were the main sources of peptides, and these peptides covered large parts of the parental proteins’ sequences. Release of peptides was concentrated to specific regions, such as residues 70–92 of β-casein in human milk, residues 39–55 of β-lactoglobulin in infant formula, and residues 57–96 and 145–161 of β-CN in infant formula, where resistance to gastrointestinal digestion was suggested. In the context of bioactive peptides, release of fragments containing known bioactive peptides was confirmed, such as β-CN-derived opioid and antihypertensive peptides. It is therefore likely that these fragments are of biological significance in neonatal health and development.",
keywords = "Bioactive peptides, Human milk, Infant formula, Milk proteins, Suckling rat pups",
author = "Yasuaki Wada and Phinney, {Brett S.} and Darren Weber and Bo L{\"o}nnerdal",
year = "2017",
month = "2",
day = "1",
doi = "10.1016/j.peptides.2016.11.012",
language = "English (US)",
volume = "88",
pages = "18--31",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - In vivo digestomics of milk proteins in human milk and infant formula using a suckling rat pup model

AU - Wada, Yasuaki

AU - Phinney, Brett S.

AU - Weber, Darren

AU - Lönnerdal, Bo

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Human milk is the optimal mode of infant feeding for the first several months of life, and infant formulas serve as an alternative when breast-feeding is not possible. Milk proteins have a balanced amino acid composition and some of them provide beneficial bioactivities in their intact forms. They also encrypt a variety of bioactive peptides, possibly contributing to infant health and growth. However, there is limited knowledge of how milk proteins are digested in the gastrointestinal tract and bioactive peptides are released in infants. A peptidomic analysis was conducted to identify peptides released from milk proteins in human milk and infant formula, using a suckling rat pup model. Among the major milk proteins targeted, α-lactalbumin and β-casein in human milk, and β-lactoglobulin and β-casein in infant formula were the main sources of peptides, and these peptides covered large parts of the parental proteins’ sequences. Release of peptides was concentrated to specific regions, such as residues 70–92 of β-casein in human milk, residues 39–55 of β-lactoglobulin in infant formula, and residues 57–96 and 145–161 of β-CN in infant formula, where resistance to gastrointestinal digestion was suggested. In the context of bioactive peptides, release of fragments containing known bioactive peptides was confirmed, such as β-CN-derived opioid and antihypertensive peptides. It is therefore likely that these fragments are of biological significance in neonatal health and development.

AB - Human milk is the optimal mode of infant feeding for the first several months of life, and infant formulas serve as an alternative when breast-feeding is not possible. Milk proteins have a balanced amino acid composition and some of them provide beneficial bioactivities in their intact forms. They also encrypt a variety of bioactive peptides, possibly contributing to infant health and growth. However, there is limited knowledge of how milk proteins are digested in the gastrointestinal tract and bioactive peptides are released in infants. A peptidomic analysis was conducted to identify peptides released from milk proteins in human milk and infant formula, using a suckling rat pup model. Among the major milk proteins targeted, α-lactalbumin and β-casein in human milk, and β-lactoglobulin and β-casein in infant formula were the main sources of peptides, and these peptides covered large parts of the parental proteins’ sequences. Release of peptides was concentrated to specific regions, such as residues 70–92 of β-casein in human milk, residues 39–55 of β-lactoglobulin in infant formula, and residues 57–96 and 145–161 of β-CN in infant formula, where resistance to gastrointestinal digestion was suggested. In the context of bioactive peptides, release of fragments containing known bioactive peptides was confirmed, such as β-CN-derived opioid and antihypertensive peptides. It is therefore likely that these fragments are of biological significance in neonatal health and development.

KW - Bioactive peptides

KW - Human milk

KW - Infant formula

KW - Milk proteins

KW - Suckling rat pups

UR - http://www.scopus.com/inward/record.url?scp=85006761762&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006761762&partnerID=8YFLogxK

U2 - 10.1016/j.peptides.2016.11.012

DO - 10.1016/j.peptides.2016.11.012

M3 - Article

C2 - 27979737

AN - SCOPUS:85006761762

VL - 88

SP - 18

EP - 31

JO - Peptides

JF - Peptides

SN - 0196-9781

ER -